Cramer Rosenthal McGlynn’s ACV Auctions ACVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.6M Sell
3,924,599
-332,082
-8% -$2.17M 1.22% 30
2025
Q4
$34.1M Buy
4,256,681
+1,321,877
+45% +$10.7M 2.2% 12
2025
Q3
$29.1M Buy
2,934,804
+147,058
+5% +$1.88M 1.81% 18
2025
Q2
$45.2M Buy
2,787,746
+69,289
+3% +$1.08M 3.11% 2
2025
Q1
$38.3M Buy
2,718,457
+480,671
+21% +$8.85M 2.76% 3
2024
Q4
$48.3M Buy
2,237,786
+30,641
+1% +$620K 2.73% 3
2024
Q3
$44.9M Buy
2,207,145
+342,781
+18% +$6.32M 2.49% 3
2024
Q2
$34M Buy
1,864,364
+333,628
+22% +$6M 2% 11
2024
Q1
$28.7M Sell
1,530,736
-153,106
-9% -$2.4M 1.56% 25
2023
Q4
$25.5M Buy
1,683,842
+525,927
+45% +$7.71M 1.39% 31
2023
Q3
$17.6M Buy
1,157,915
+610,692
+112% +$9.92M 0.98% 42
2023
Q2
$9.45M Buy
547,223
+202,148
+59% +$3.09M 0.47% 75
2023
Q1
$4.45M Buy
+345,075
New +$3.77M 0.2% 92

Other funds holding ACVA

Cramer Rosenthal McGlynn's ACVA Position: Q1 2026 in Review

Cramer Rosenthal McGlynn reduced its ACV Auctions (ACVA) stake by 7.8% in Q1 2026, selling an estimated $2.17M and leaving 3,924,599 shares worth $16.6M. The position accounts for 1.22% of the portfolio, ranked #30.

Cramer Rosenthal McGlynn first reported a position in ACVA in Q1 2023 and has held it in 13 quarters since. The position peaked at $48.3M in Q4 2024. 265 funds tracked by Wall St. Rank hold ACVA as of Q1 2026.

  • Cramer Rosenthal McGlynn held 3,924,599 shares of ACV Auctions worth $16.6M as of Q1 2026.
  • Cramer Rosenthal McGlynn sold 332,082 ACV Auctions shares in Q1 2026, an estimated $2.17M.
  • ACV Auctions made up 1.22% of Cramer Rosenthal McGlynn's portfolio in Q1 2026, its #30 holding.
  • Cramer Rosenthal McGlynn first reported a position in ACV Auctions in Q1 2023 and has held it in 13 quarters since.
  • Cramer Rosenthal McGlynn's ACV Auctions position peaked at $48.3M in Q4 2024.
  • 265 funds tracked by Wall St. Rank held ACV Auctions as of Q1 2026.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2026, filed 15 May 2026.